A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869) (Abbott Laboratories M11-306).

Trial Profile

A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869) (Abbott Laboratories M11-306).

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2011

At a glance

  • Drugs Ketoconazole; Linifanib
  • Indications Cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 17 Mar 2011 Planned End Date changed from 1 Oct 2012 to 1 Oct 2011 as reported by ClinicalTrials.gov.
    • 17 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 04 May 2010 Actual initiation date (Apr 2010), planned patient no [12], trial investigator [McKee MD] added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top